Sort
23,748 grants matching “melanoma”
RAS and injury: ACE and resistance to cancer and viral infection
$326,463Kenneth E Bernstein · Cedars-Sinai Medical Center · R01 · FY2008 · DK
Gamma Delta T Cell Immunotherapy of Breast Cancer
$326,444Richard D Lopez · University Of Alabama At Birmingham · P50 · FY2011 · CA
Lassa-VSV targets and kills glioma, and is not neurotoxic
$326,384Murat Gunel · Yale University · R01 · FY2020 · CA
SOUTHWEST ONCOLOGY GROUP
$326,345University Of Texas Hlth Sci Ctr San Ant · U10 · FY2000 · CA
Mechanical regulation of the microenvironmental niche in skin tumorigenesis
$326,283Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
FOCAL ADHESION KINASE--TUMOR BIOLOGY AND THERAPEUTICS
$326,250University Of North Carolina Chapel Hill · R01 · FY2000 · CA
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
$326,250Colorado State University-Fort Collins · R01 · FY2004 · CA
TUMOR ANGIOGENESIS INHIBITIION BY SYSTEMIC GENE DELIVERY
$326,250Colorado State University-Fort Collins · R01 · FY2003 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$326,245Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Chemical Inhibitors of CREB-mediated Gene Transcription
$326,240Xiangshu Xiao · Oregon Health & Science University · R01 · FY2010 · GM
A novel T-cell subset able to kill relapsed cancers
$326,231Qing Yi · Methodist Hospital Research Institute · R01 · FY2018 · CA
BLIMP-1 mediated regulation of CD8+ TIL
$326,220Timothy N Bullock · University Of Virginia · R01 · FY2015 · CA
Layer-by-layer nanocarriers for highly efficient solubilization of insoluble drug
$326,209Vladimir P Torchilin · Northeastern University · R01 · FY2010 · CA
Topical Chemoprevention of Skin Cancer Biomarkers
$326,174Craig A Elmets · University Of Alabama At Birmingham · R01 · FY2019 · CA
UV damage, repair, and mutagenesis
$326,174Gerd P Pfeifer · Beckman Research Institute/City Of Hope · R37 · FY2007 · ES
Strategies to Enhance Post-Transplant Tumor Vaccination
$326,165Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Subcellular/Cell Cycle Boron-Delivery Studies of Unnatural Amino Acids by SIMS
$326,067Subhash Chandra · Cornell University · R01 · FY2009 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$326,066Charles L Sentman · Dartmouth College · R01 · FY2014 · CA
Design of Therapeutic Strategies Specific for Breast Cancer Initiating Cells
$326,066Germana Rappa · Nevada Cancer Institute · R01 · FY2011 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$326,066Young J. Kim · Johns Hopkins University · R01 · FY2014 · CA
Designing Lymph Nodes for Cancer Immunotherapy
$326,045James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Telomere-Mediated Protective Responses in Skin
$326,032Boston University Medical Campus · R01 · FY2004 · CA
Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis
$325,976Timothy A Marlowe · Faknostics, Llc · R42 · FY2024 · DK
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
$325,879Denise C Connolly · Fox Chase Cancer Center · R01 · FY2010 · CA
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
$325,879Denise C Connolly · Fox Chase Cancer Center · R01 · FY2009 · CA